<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01091194</url>
  </required_header>
  <id_info>
    <org_study_id>10920</org_study_id>
    <nct_id>NCT01091194</nct_id>
  </id_info>
  <brief_title>Effect of Exercise After Heart Transplantation</brief_title>
  <acronym>TEX</acronym>
  <official_title>Effect of High Intensity Interval-based Aerobic Exercise 1-8 Years After Heart Transplantation. 1 Year Follow Up.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Oslo University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Helse Sor-Ost</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Oslo University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a randomized controlled trial which will include approximately 50 heart transplant
      recipients 1-8 years after heart transplantation. The intervention and follow up period is 1
      year. The primary purpose is to investigate if systematic, high intensity, interval-based
      aerobic exercise training results in a greater improvement of exercise capacity (measured by
      VO2peak) than previously shown in heart transplant recipients.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>October 2009</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">October 2011</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Peak oxygen uptake (VO2peak)</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Isokinetic muscle strength of quadriceps and hamstrings</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life measured by questionnaires</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Myocardial function measured by echocardiography</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Progression on coronary atherosclerosis measured by intra vascular ultrasound (IVUS)</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Vascular tone and compliance measured by tonometry</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Regular blood screening, lipid profile, inflammatory status, nerve growth factor, biochemical markers for endothelial function, prothrombotic factor, factors connected to vascularization: NT-proBNP and gene expression analysis.</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Analysis of isolated muscle cells from myocardial biopsy</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reinnervation as judged by autonomic nervous control (Heart Rate Variability)</measure>
    <time_frame>Before and after the intervention period of 1 year</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">51</enrollment>
  <condition>Heart Transplantation</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Interval-based aerobic exercise</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>No intervention other than regular follow up hospital visits</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Interval-based aerobic exercise</intervention_name>
    <description>High intensity interval-based aerobic exercise training. Duration: 1 year. Three 8-weeks supervised periods of physical training 3 times per week. Individual training 2 times per week between these periods.</description>
    <arm_group_label>Exercise</arm_group_label>
    <other_name>physical activity, fitness</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Norwegian heart transplanted patients &gt; 18 years of age

          -  1-8 years after heart transplantation

          -  Optimal medical treatment

          -  Stable condition

          -  Written informed consent

          -  Must have access to a physical therapist or personal trainer in their hometown

          -  Motivation for exercise

        Exclusion Criteria:

          -  Unstable condition

          -  In need of revascularization or other invention

          -  Infections, open wounds or skin diseases

          -  Physical disabilities which prevent participation

          -  Other diseases, illnesses or conditions which contradict exercise
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Lars Gullestad, MD,PhD,Prof.</last_name>
    <role>Study Director</role>
    <affiliation>Oslo University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Department of Cardiology, Oslo University Hospital, Rikshospitalet</name>
      <address>
        <city>Oslo</city>
        <zip>0027</zip>
        <country>Norway</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Norway</country>
  </location_countries>
  <results_reference>
    <citation>Nytrøen K, Rustad LA, Aukrust P, Ueland T, Hallén J, Holm I, Rolid K, Lekva T, Fiane AE, Amlie JP, Aakhus S, Gullestad L. High-intensity interval training improves peak oxygen uptake and muscular exercise capacity in heart transplant recipients. Am J Transplant. 2012 Nov;12(11):3134-42. doi: 10.1111/j.1600-6143.2012.04221.x. Epub 2012 Aug 17.</citation>
    <PMID>22900793</PMID>
  </results_reference>
  <results_reference>
    <citation>Rustad LA, Nytrøen K, Amundsen BH, Gullestad L, Aakhus S. One year of high-intensity interval training improves exercise capacity, but not left ventricular function in stable heart transplant recipients: a randomised controlled trial. Eur J Prev Cardiol. 2014 Feb;21(2):181-91. doi: 10.1177/2047487312469477. Epub 2012 Nov 26.</citation>
    <PMID>23185084</PMID>
  </results_reference>
  <results_reference>
    <citation>Nytrøen K, Rustad LA, Gude E, Hallén J, Fiane AE, Rolid K, Holm I, Aakhus S, Gullestad L. Muscular exercise capacity and body fat predict VO(2peak) in heart transplant recipients. Eur J Prev Cardiol. 2014 Jan;21(1):21-9. doi: 10.1177/2047487312450540. Epub 2012 Jun 1.</citation>
    <PMID>22659939</PMID>
  </results_reference>
  <verification_date>February 2013</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 18, 2010</study_first_submitted>
  <study_first_submitted_qc>March 22, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 23, 2010</study_first_posted>
  <last_update_submitted>February 18, 2013</last_update_submitted>
  <last_update_submitted_qc>February 18, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 20, 2013</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Heart Transplantation</keyword>
  <keyword>Aerobic Exercise</keyword>
  <keyword>Exercise, Physical</keyword>
  <keyword>Exercise Test</keyword>
  <keyword>Treadmill Test</keyword>
  <keyword>VO2 peak</keyword>
  <keyword>Muscle Strength</keyword>
  <keyword>Quality of Life</keyword>
  <keyword>Reinnervation</keyword>
  <keyword>Heart Rate</keyword>
  <keyword>Myocardial Function</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

